ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

SABS SAB Biotherapeutics Inc

2,64
0,05 (1,93%)
25 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
SAB Biotherapeutics Inc SABS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,05 1,93% 2,64 01:00:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,58 2,51 2,80 2,72 2,59
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/05/202418:45GLOBESAB Biotherapeutics Announces Q1 2024 Financial Results and..
06/05/202408:15GLOBESAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of..
16/04/202408:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
08/04/202408:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
04/04/202408:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
29/03/202408:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
25/03/202411:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
23/02/202410:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
08/02/202410:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
02/02/202409:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
23/01/202419:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
02/01/202418:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
29/11/202309:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
20/11/202309:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
14/11/202309:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
14/11/202309:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
09/11/202309:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
24/10/202308:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
19/10/202308:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
05/10/202308:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
02/10/202308:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
21/08/202309:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
21/06/202309:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..
30/05/202309:30GLOBESAB Biotherapeutics to Present Novel Human IgG Platform with..

Seu Histórico Recente

Delayed Upgrade Clock